Clinical variability of Waardenburg-Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus

2009 ◽  
Vol 149A (10) ◽  
pp. 2290-2295 ◽  
Author(s):  
Beyhan Tüysüz ◽  
Anna Collin ◽  
Müjde Arapoğlu ◽  
Nezir Suyugül
2000 ◽  
Vol 36 (Supplement 1) ◽  
pp. S290-S291 ◽  
Author(s):  
Chantal Langlois ◽  
Sophie Tessier ◽  
Alexandre Brkovic ◽  
Alain Fournier

1997 ◽  
Vol 158 (5) ◽  
pp. 1966-1972 ◽  
Author(s):  
M.E. Sullivan ◽  
M.R. Dashwood ◽  
C.S. Thompson ◽  
J.R. Muddle ◽  
D.P. Mikhailidis ◽  
...  

Blood ◽  
2008 ◽  
Vol 112 (3) ◽  
pp. 856-865 ◽  
Author(s):  
Nitin Patel ◽  
Caryn S. Gonsalves ◽  
Punam Malik ◽  
Vijay K. Kalra

Abstract Pulmonary hypertension (PHT) develops in sickle cell disease (SCD) and is associated with high mortality. We previously showed that erythroid cells produce placenta growth factor (PlGF), which activates monocytes to induce proinflammatory cytochemokines, contributing to the baseline inflammation and severity in SCD. In this study, we observed that PlGF increased expression of endothelin-1 (ET-1) and endothelin-B receptor (ET-BR) from human pulmonary microvascular endothelial cells (HPMVECs) and monocytes, respectively. PlGF-mediated ET-1 and ET-BR expression occurred via activation of PI-3 kinase, reactive oxygen species and hypoxia inducible factor-1α (HIF-1α). PlGF increased binding of HIF-1α to the ET-1 and ET-BR promoters; this effect was abrogated with mutation of hypoxia response elements in the promoter regions and HIF-1α siRNA and confirmed by chromatin immunoprecipitation analysis. Furthermore, PlGF-mediated ET-1 release from HPMVECs and ET-BR expression in monocytes creates a PlGF–ET-1–ET-BR loop, leading to increased expression of MCP-1 and IL-8. Our studies show that PlGF-induced expression of the potent vasoconstrictor ET-1 and its cognate ET-BR receptor occur via activation of HIF-1α, independent of hypoxia. PlGF levels are intrinsically elevated from the increased red cell turnover in SCD and in other chronic anemia (eg, thalassemia) and may contribute to inflammation and PHT seen in these diseases.


2005 ◽  
Vol 21 (12) ◽  
pp. 960-963 ◽  
Author(s):  
Surasak Sangkhathat ◽  
Piyawan Chiengkriwate ◽  
Takeshi Kusafuka ◽  
Sakda Patrapinyokul ◽  
Masahiro Fukuzawa

2008 ◽  
Vol 46 (1) ◽  
pp. 36-40 ◽  
Author(s):  
Yu-Cheng Lin ◽  
Hong-Shiee Lai ◽  
Wen-Ming Hsu ◽  
Ping-Ing Lee ◽  
Huey-Ling Chen ◽  
...  

Circulation ◽  
2002 ◽  
Vol 106 (15) ◽  
pp. 1991-1998 ◽  
Author(s):  
Nobuyuki Murakoshi ◽  
Takashi Miyauchi ◽  
Yoshihiko Kakinuma ◽  
Takashi Ohuchi ◽  
Katsutoshi Goto ◽  
...  

2000 ◽  
Vol 36 ◽  
pp. S260-S261
Author(s):  
Cecil S. Thompson ◽  
Masood A. Khan ◽  
Michael R. Dashwood ◽  
Faiz H. Mumtaz ◽  
Dimitri P. Mikhailidis ◽  
...  

2017 ◽  
Vol 15 (6) ◽  
pp. 3658-3664 ◽  
Author(s):  
Yue-Ping Wang ◽  
Da-Jia Wang ◽  
Zhi-Bin Niu ◽  
Wan-Ting Cui

Sign in / Sign up

Export Citation Format

Share Document